Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00142207Phase 3Completed
Phase 3, randomised, open-label trial of sulfadoxine + pyrimethamine in malaria (3 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoints: Mean birthweight and Prevalence of low birthweight. Started Jan 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00142207.